Capricor Therapeutics Inc (CAPR) — Cash Flow Quality Index
Capricor Therapeutics Inc (CAPR) has a Cash Flow Quality Index of -0.22x as of December 2017. Operating cash flow of $-2.67 Million is below net income of $12.31 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Capricor Therapeutics Inc to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Capricor Therapeutics Inc Cash Flow Quality Index (2017–2017)
Historical Cash Flow Quality Index for Capricor Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Capricor Therapeutics Inc (CAPR) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Capricor Therapeutics Inc (2017–2017)
Year-by-year earnings quality comparison for Capricor Therapeutics Inc. For live market cap and the full company financial profile, see Capricor Therapeutics Inc market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2017 | -5.85x | $-14.23 Million | $2.43 Million | — |